EWM
IGC icon

Evermay Wealth Management’s IGC Pharma IGC Stock Holding History

Evermay Wealth Management’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-30
Closed -$13 – 584
2025
Q3 		$13 Hold
30
– – ﹤0.01% 555
2025
Q2 		$10 Hold
30
– – ﹤0.01% 568
2025
Q1 		$9 Hold
30
– – ﹤0.01% 576
2024
Q4 		$11 Buy
+30
New +$11 ﹤0.01% 569
2022
Q3 		– Sell
-30
Closed – – 529
2022
Q2 		$0 Hold
30
– – ﹤0.01% 537
2022
Q1 		$0 Hold
30
– – ﹤0.01% 550
2021
Q4 		$0 Hold
30
– – ﹤0.01% 522
2021
Q3 		$0 Hold
30
– – ﹤0.01% 493
2021
Q2 		$0 Buy
+30
New +$46 ﹤0.01% 508

Other funds holding IGC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $148M AUM

Evermay Wealth Management's IGC Position: Q4 2025 in Review

Evermay Wealth Management sold out of IGC Pharma (IGC) in Q4 2025, closing a stake of 30 shares — an estimated $13 sold.

Evermay Wealth Management first reported a position in IGC in Q2 2021 and held it in 9 quarters. The position peaked at $13 in Q3 2025. 30 funds tracked by Wall St. Rank hold IGC as of Q4 2025.

  • Evermay Wealth Management reported no remaining IGC Pharma position as of Q4 2025 after selling out during the quarter.
  • Evermay Wealth Management sold 30 IGC Pharma shares in Q4 2025, an estimated $13.
  • Evermay Wealth Management first reported a position in IGC Pharma in Q2 2021 and held it in 9 quarters.
  • Evermay Wealth Management's IGC Pharma position peaked at $13 in Q3 2025.
  • 30 funds tracked by Wall St. Rank held IGC Pharma as of Q4 2025.

Based on Evermay Wealth Management's 13F filing for Q4 2025, filed 22 Jan 2026.